The antitrust class action initiated in Michigan against Blue Cross Blue Shield of Michigan has been deemed a “case to watch” by reports as the trial, which is scheduled to begin next year, will offer a rare legal analysis into the effects of so-called most-favored-nation clauses. The lawsuit alleges that BCBS broke antitrust law through such clauses in its contracts, as the agreements ensured that hospitals did not pay more to BCBS competitors. The agreements are gradually becoming outlawed in various states; North Carolina was the latest state to deem the provisions illegal earlier this month. Despite legislative action against the contractual clauses, rarely have they been tested in a court of law. The class action is seeking unspecified damages to compensate for alleged overcharges for consumers as a result of the clauses.
Featured News
Perkins Coie Adds Former DOJ Antitrust Leader as Partner in Washington
Jan 22, 2026 by
CPI
Ryanair Boss Dismisses Musk’s Buyout as Starlink Feud Escalates
Jan 22, 2026 by
CPI
Paramount Extends Warner Bros Bid as Netflix Rivalry Heats Up
Jan 22, 2026 by
CPI
South Korea Breaks New Ground With Landmark AI Law
Jan 22, 2026 by
CPI
NYDFS Warns Banks They Can’t Outsource Vendor Risk
Jan 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Recidivism
Jan 21, 2026 by
CPI
Recidivism, Multiple Offending, and Serial Offending in Antitrust
Jan 21, 2026 by
Gregory Werden
Antitrust Recidivism: Why Repeat Cases Appear, and Why True Reoffending Is Rare in the United States
Jan 21, 2026 by
Lisa M. Phelan, Megan S. Golden, Adrienne Irmer & Nina Worth
99 Antitrust Problems – Is Recidivism One?
Jan 21, 2026 by
Brian A. Ratner & Kartik S. Madiraju
Holding A Cat by the Tail: A View of Cartel Recidivism in U.S. Antitrust Enforcement
Jan 21, 2026 by
Mark Rosman & KaDee L. Ru